WebDisclosure WebDisclosure
Basculer en Français
9887 Companies
199002 Keywords
129938 Articles
105788 Press releases
Headlines Articles Press releases Dr. Falk Pharma GmbH Remove
  1. Home
  2. Companies
  3. Dr. Falk Pharma GmbH
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 10/29/2024 at 13:05, 1 year 3 months ago

    Dr. Falk Pharma Acquires Kynos Therapeutics, Enhancing Portfolio in Inflammatory Diseases

    Inflammatory Diseases Dr. Falk Pharma Kynos Therapeutics Acute Pancreatitis KNS366
  • BRIEF

    published on 10/29/2024 at 13:05, 1 year 3 months ago

    Dr. Falk Pharma acquiert Kynos Therapeutics, enrichissant ainsi son portefeuille dans le domaine des maladies inflammatoires

    Maladies Inflammatoires Dr. Falk Pharma KNS366 Thérapeutique Kynos Pancréatite Aiguë
  • PRESS RELEASE

    published on 10/29/2024 at 13:00, 1 year 3 months ago

    Dr. Falk Pharma Acquires Kynos Therapeutics, Adding Acute Pancreatitis as a Therapeutic Focus and Further Strengthening Its Development Portfolio

    Dr. Falk Pharma GmbH acquires Kynos Therapeutics Ltd., focusing on inflammatory disease treatments. KNS366, a novel enzyme inhibitor, shows promise in clinical trials for acute pancreatitis
    Inflammatory Diseases Dr. Falk Pharma Kynos Therapeutics Acute Pancreatitis KNS366
    Logo of Dr. Falk Pharma GmbH
Accesswire
  • Published on 02/18/2026 at 15:15, 1 hour 46 minutes ago

    Host of "The Schaftlein Report" on Patriot.TV Delivers Urgent Warning to Trump: 2026 Midterm Course Correction Needed Now

  • Published on 02/18/2026 at 15:00, 2 hours 1 minute ago

    Jaguar Health Announces a Special One-time Stock Dividend

  • Published on 02/18/2026 at 14:25, 2 hours 36 minutes ago

    Mako Mining Announces Amended and Restated Definitive Agreements for Restructure of Mt. Hamilton Acquisition Consideration and Filing of Supplement to Management Information Circular

  • Published on 02/18/2026 at 14:00, 3 hours 1 minute ago

    Revolve Achieves Key Interconnection Milestone On 130 MW "El 24 Wind Project" In Mexico

  • Published on 02/18/2026 at 14:00, 3 hours 1 minute ago

    Datametrex Receives $1M Order from Fortune 500 Client

View all ACCESSWIRE
EQS Group
  • Published on 02/18/2026 at 15:50, 1 hour 10 minutes ago

    CGTN: Private economy: A key actor in advancing China's economic priorities in 2026 and beyond

  • Published on 02/18/2026 at 15:48, 1 hour 12 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group PLC

  • Published on 02/18/2026 at 15:47, 1 hour 13 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Schroders PLC

  • Published on 02/18/2026 at 15:46, 1 hour 14 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Ltd

  • Published on 02/18/2026 at 15:44, 1 hour 16 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: NCC Group PLC

View all EQS
Les Echos
  • Published on 02/18/2026 at 13:45, 3 hours 15 minutes ago

    NRJ GROUP - Non renouvellement Licence FM Nationale NRJ Suède

  • Published on 02/18/2026 at 11:00, 6 hours ago

    Mise à disposition des documents préparatoires à l'AG

  • Published on 02/18/2026 at 08:07, 8 hours 54 minutes ago

    TERACT - Changes to Financial calendar

  • Published on 02/18/2026 at 08:07, 8 hours 54 minutes ago

    TERACT - Modification du calendrier financier

  • Published on 02/18/2026 at 07:30, 9 hours 31 minutes ago

    PR Carrefour - Vusion

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy